MoneyWorks4Me

Gujarat Terce Laboratories informs about outcome of board meeting

17 Dec 2018 Evaluate

Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Gujarat Terce Laboratories has informed that the Board of Directors, at its meeting held today, December 17, 2018, has considered the resignation of Amritbhai Purushotamdas Prajapati from one of the posts, Chief Financial Officer (CFO) only of the company; and appointment of Bhagirath Ramhit Maurya as Chief Financial Officer (CFO) of the company. The Board meeting commenced at 12:00 PM and concluded at 12:35 PM.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1849.95
Dr. Reddys Labs. 1199.45
Cipla 1404.00
Lupin 2084.00
Zydus Lifesciences 1193.55
View more..